Parathyroid Hormone: Clinical Trials

37 trials of Parathyroid Hormone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 completed, 5 terminated, 3 unknown, 1 suspended. 13 Phase 2, 9 Phase 3, 7 Phase 4, 5 Phase 1, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 213Completed 11, Terminated 2
Phase 39Completed 7, Terminated 1, Unknown 1
Phase 47Completed 4, Suspended 1, Terminated 1, Unknown 1
Phase 15Completed 3, Terminated 1, Withdrawn 1
Early Phase 12Completed 1, Unknown 1

Follow Parathyroid Hormone: new trials by email Literature Review of Parathyroid Hormone trials Research Report on Parathyroid Hormone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fibroblast Growth Factor 23 and Sclerostin in Relation to Calcium in COVID-19 Patients
Calcium, Fibroblast growth factor 23, Sclerostin - COVID-19
CompletedAswan University Hospital662022-05-012023-02-14
A Study of Relative Bioavailability of a New Formulation Compared With the Approved Formulation of rhPTH [1-84] and to Find Out Dose Linearity of the New Formulation in Healthy Adults
rhPTH(1-84) - Healthy Volunteers
Phase 1CompletedTakeda962021-11-292023-12-15
Parathyroid Hormone Kinetics During CRRT
parathyroid hormone - Critical Illness, Multi Organ Failure
CompletedUniwersytecki Szpital Kliniczny w Opolu302019-05-062022-01-14
Oral PTH(1-34) PK and PD Study in Patients With Hypoparathyroidism
EB612 (EBP05), NATPARA/NATPAR - Hypoparathyroidism
Phase 2CompletedEntera Bio Ltd.202018-06-172019-03-26
Corticosteroid Rhythms in Hypoparathyroid Patients
parathyroid hormon 1-84 - Hypoparathyroidism, Hyperparathyroidism
Early Phase 1UnknownUniversity of Bergen302016-03-012017-10-27
A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen
ZP-PTH, FORTEO - Postmenopausal Osteoporosis
Phase 1CompletedZosano Pharma Corporation242015-06-012016-08-23
One Week Comparison Study of PTH and PTHrP Infusions
Parathyroid Hormone-related Protein (1-36), parathyroid hormone (1-34), PTH (1-34) and PTHrP (1-36) - Osteoporosis, Hypercalcemia of Malignancy
Phase 1WithdrawnUniversity of Pittsburgh2015-01-012014-12-05
Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot
Teriparatide, Placebo - Diabetic Neuropathic Arthropathy
Phase 2CompletedPost Graduate Institute of Medical Education and Research, Chandigarh202014-01-012021-06-30
A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects
Teriparatide, Oral PTH (1-34) - Drug Safety and Bioavailability
Phase 1CompletedEntera Bio Ltd.302013-10-012018-01-10
Treatment With PTH After Sternotomy in Cardiac Surgery Patients
Parathyroid hormone, Placebo - Disruption or Dehiscence of Closure of Sternum or Sternotomy
Phase 3CompletedUniversity of Aarhus202012-10-012014-06-02
Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo
Denosumab, Teriparatide, Placebo Denosumab - Bone Marrow Oedema Syndrome, High Turnover Bone Disease
Phase 4SuspendedMedical University of Vienna902012-05-012015-09-23
Parathyroid Hormone for the Treatment of Humerus Fractures
1-84 parathyroid hormone, Placebo - Shoulder Fractures
Phase 4UnknownHvidovre University Hospital722012-03-012012-09-18
Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion
teriparatide, Placebo - Lumbar Spondylosis, Lumbar Spondylolisthesis
Phase 4CompletedShane Burch362011-08-012021-05-03
ADD-ON Study to Existing Hypoparathyroidism Studies
PTH1-84 in parent study - Hypoparathyroidism
Phase 3UnknownNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)622010-09-012018-02-28
HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism
open-label PTH(1-84) - Hypoparathyroidism
Phase 3CompletedColumbia University622009-12-012024-07-05
A Study for the Transdermal Application of Teriparatide
Subcutaneous Teriparatide, Transdermal Teriparatide - Osteoporosis
Phase 2CompletedEli Lilly and Company2332009-11-012012-10-23
Comparison Study of PTHrP and PTH to Treat Osteoporosis
Parathyroid hormone related protein (1-36), Parathyroid hormone related protein(1-36), Parathyroid hormone (1-34) - Osteoporosis
Phase 2CompletedUniversity of Pittsburgh1052009-05-012016-03-24
Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
Teriparatide (PTH 1-34) - Menopause, Fracture
Phase 2 / Phase 3CompletedColumbia University222008-08-202018-07-26
Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia
Teriparatide (Forteo), Calcium, Calcitriol - Hypocalcemia
Phase 2TerminatedM.D. Anderson Cancer Center72008-05-012012-12-06
PTH & Ibandronate Combination Study (PICS)
PTH(1-84), Ibandronate, Placebo injection - Osteoporosis
Phase 2 / Phase 3CompletedUniversity of California, San Francisco442008-05-012013-11-05

Showing 20 of 37. Sign in to see all of them.

Conditions studied

Osteoporosis (15)  ·  Hypoparathyroidism (6)  ·  Osteoporosis, Postmenopausal (4)  ·  Hyperparathyroidism (3)  ·  Hypocalcemia (3)  ·  Bone Diseases, Endocrine (2)  ·  Bone Diseases, Metabolic (2)  ·  Endocrine System Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Acute Kidney Injury (1)  ·  Anemia, Aplastic (1)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Back Pain (1)  ·  COVID-19 (1)  ·  Critical Illness (1)

Sponsors

Nycomed (4)  ·  Takeda (3)  ·  University of Pittsburgh (3)  ·  Columbia University (2)  ·  Entera Bio Ltd. (2)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)  ·  Zosano Pharma Corporation (2)  ·  Aswan University Hospital (1)  ·  Eli Lilly and Company (1)  ·  Helen Hayes Hospital (1)  ·  Hvidovre University Hospital (1)  ·  John P. Bilezikian (1)  ·  M.D. Anderson Cancer Center (1)  ·  Massachusetts General Hospital (1)  ·  Medical University of Vienna (1)

Countries

United States (20)  ·  Denmark (7)  ·  Argentina (1)  ·  Austria (1)  ·  Egypt (1)  ·  Estonia (1)  ·  Germany (1)  ·  Hungary (1)  ·  India (1)  ·  Israel (1)  ·  Mexico (1)  ·  Norway (1)  ·  Poland (1)  ·  Romania (1)

Top investigators

John P Bilezikian, MD (3)  ·  Mara J. Horwitz, MD (2)  ·  Adi Cohen, MD (1)  ·  Anil Bhansali, DM (1)  ·  Arthur Santora, MD (1)  ·  Asmaa Abdelmageed Muhammed, Lecturer (1)  ·  Carmen Li (1)  ·  Christian Muschitz, MD (1)  ·  Colleen Delaney, MD (1)  ·  David Avigan, MD (1)  ·  Dennis M. Black, PhD (1)  ·  Edward Ball, M.D. (1)  ·  Elizabeth J Shpall, MD (1)

Results publications

PMID 16684825, PMID 19858319, PMID 21155613, PMID 21544866, PMID 22766223, PMID 22791766, PMID 23589163, PMID 29972871, PMID 34010434, PMID 36018496, PMID 39167533

NIH funding

2005 (1), P50AR039191 (1), P50AR044855 (1), R01DK051081 (1), R01DK069350 (1), R01DK073039 (1), U54HL081030 (1)